Abnormal levels of CgA, detected by immunoassay, are present in the blood of patients with neuroendocrine tumors or with other diseases, such as cardiovascular, gastrointestinal, renal, and inflammatory diseases [3]. Here, CGA is linked to neuroendocrine neoplasm.